Dschietzig TB, Salama G. Relaxin-2 for heart failure with preserved ejection fraction: a comment on the termination of a phase-II trial investigating the relaxin-2 analogue, LY3540378. Global Cardiol [Internet]. 2024 Dec. 30 [cited 2025 Jan. 4];2(4). Available from: https://www.globalcardiology.info/site/article/view/56